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Abstract
Macrophage-like synoviocytes and fibroblast-like synoviocytes
(FLS) are known as the most active cells of rheumatoid arthritis
(RA) and are close to the articular cartilage in a position enabling
them to invade the cartilage. Macrophage-like synoviocytes and
FLS expression of matrix metalloproteinases (MMPs) and their
interaction has aroused great interest. The present article
studied the expression of CD147, also called extracellular matrix
metalloproteinase inducer, on monocytes/macrophages and
FLS from RA patients and its potential role in enhancing MMPs
and the invasiveness of synoviocytes. Expression of CD147 on
FLS derived from RA patients and from osteoarthritis patients,
and expression of CD147 on monocytes/macrophages from
rheumatic synovial fluid and healthy peripheral blood were
analyzed by flow cytometry. The levels of CD147, MMP-2 and
MMP-9 mRNA in FLS were detected by RT-PCR. The role of
CD147 in MMP production and the cells' invasiveness in vitro
were studied by the co-culture of FLS with the human THP-1 cell
line or monocytes/macrophages, by gel zymography and by
invasion assay. The results showed that the expression of
CD147 was higher on RA FLS than on osteoarthritis FLS and
was higher on monocytes/macrophages from rheumatic
synovial fluid than on monocytes/macrophages from healthy
peripheral blood. RT-PCR showed that the expressions of
CD147, MMP-2 and MMP-9 mRNA was higher in RA FLS than
in osteoarthritis FLS. A significantly elevated secretion and
activation of MMP-2 and MMP-9 were observed in RA FLS co-
cultured with differentiated THP-1 cells or RA synovial
monocytes/macrophages, compared with those co-cultured
with undifferentiated THP-1 cells or healthy control peripheral
blood monocytes. Invasion assays showed an increased number
of invading cells in the co-cultured RA FLS with differentiated
THP-1 cells or RA synovial monocytes/macrophages. CD147
antagonistic peptide inhibited the MMP production and the
invasive potential. Our studies demonstrated that the CD147
overexpression on monocytes/macrophages and FLS in RA
patients may be responsible for the enhanced MMP secretion
and activation and for the invasiveness of synoviocytes. These
findings suggest that CD147 may be one of the important
factors in progressive joint destruction of RA and that CD147
may be a potential therapeutic target in RA treatment.
Introduction
Rheumatoid arthritis (RA) is characterized by chronic prolifer-
ative synovitis, with hyperplasia of the synovial lining cells,
inflammatory cell infiltration and angiogenesis in the sublining
cell layer. Hyperplastic synovial lining cells overproduce such
matrix metalloproteinases (MMPs) as MMP-1, MMP-2, MMP-
3, MMP-9 and MT1-MMP, which may be involved in tissue
remodeling during angiogenesis and cartilage destruction.
Articular cartilage at the margins of the articular surface, to
which synovium tissue can directly attach, is progressively
degraded even in the disease's early stage. As macrophage-
like synoviocytes (MLS) and fibroblast-like synoviocytes (FLS)
are known as the most active cells and are close to the articu-
lar cartilage in a position to invade the cartilage, their expres-
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sion of MMPs and their interaction have been reported to be
related to cartilage destruction. Although IL-1 and tumor
necrosis factor alpha are reported by some studies as key reg-
ulators of matrix degradation in RA, other molecules, such as
CD147, are also thought to have played some regulatory role
in RA pathogenesis [1-4]. But very few reports have been pre-
sented on CD147 functions in cartilage destruction.
CD147, also called extracellular matrix metalloproteinase
inducer and leukocyte activation-associated M6 antigen or
HAb18G, was initially identified on the surface of human can-
cer cells and has been proven to stimulate the adjacent stro-
mal cells to produce several MMPs [5,6]. CD147 is broadly
expressed on hemopoietic and nonhemopoietic cell lines [7]
and has the function of tissue remodeling. The expression of
CD147 has been reported to be upregulated in the synovial
membrane of RA patients [8,9]. In our previous study, we
found that CD147 was expressed in synovium not only on the
fibroblast-like cells, but also on peripheral monocyte-derived
CD68+ macrophage-like cells [10].
The study reported here was designed to investigate the
expression of CD147 on FLS and THP-1 cells derived from
human monocytic leukemia cells [11], from monocytes/macro-
phages of peripheral blood and from synovial fluid in RA, and
to explore the possible functions of CD147 in the pathogene-
sis of RA.
Patients and methods
Patients
Synovium tissues were obtained from ten patients (six with RA,
four with osteoarthritis [OA]) at joint replacement surgery or
synovectomy, and samples of synovial fluid from knee joints
were obtained from ten patients with active RA. All the patients
with RA satisfied the 1987 revised diagnostic criteria of the
American College of Rheumatology [12]. The mean age of the
RA patients was 58 years (range 28–76 years) and the mean
disease duration was 10 years. Samples used as the control
were obtained from four patients with OA, who met clinical
and radiographic American College of Rheumatology criteria
for OA. The mean age of these patients was 51 years (range
46–57 years) and the mean disease duration was 12 years.
The normal control samples of peripheral blood were taken
from ten healthy human donor volunteers, with no significant
age or sex differences compared with those of the RA
patients. The ethics approval was granted for this study and all
the subjects provided their informed consent.
Cells isolation and culture
Human FLS were isolated by enzymatic dispersion of synovial
tissues obtained from RA patients or OA patients. Briefly, tis-
sues were harvested by orthopedic surgeons and collected in
sterile PBS. The tissues, with connective tissues and fat
removed, were digested with collagenase II (4 mg/ml; Sigma,
St Louis, MO, USA) in serum-free DMEM for at least one hour
at 37°C. The cell suspension was passed through a nylon
mesh and the cells were then collected by centrifugation at
800 × g for 5 minutes and were re-suspended in DMEM sup-
plemented with 10% fetal bovine serum (FBS) (Gibco, Grand
Island, NY, USA). The harvested cells were cultured in 75 cm2
culture flasks (Costar, Cambridge, MA, USA) with DMEM sup-
plemented with 1% penicillin/streptomycin and 2% L-
glutamine (Gibco) and with 10% FBS at 37°C in a humidified
atmosphere of 5% CO2. When the cells had grown to conflu-
ence they were detached with 0.25% trypsin, split in a 1:3
ratio and were re-cultured in DMEM under the same condi-
tions. To eliminate the non-adherent cells, the plated cells
were washed thoroughly with PBS. Isolated synoviocytes
were cultured in DMEM supplemented with 10% FBS. The
cells used for our experiments were at the third to fifth pas-
sage, because these cells were more purified than the first and
second passages of FLS and had better biological functions
than the cells above the fifth passage. The FLS were identified
by flow cytometric analysis as a homogeneous population
Table 1
Results of expressions of CD147 on fibroblast-like synoviocytes (FLS) and monocytes/macrophages
Osteoarthritis FLS RA FLS Undifferentiated 
THP-1 cells
PMA-induced 
differentiated 
THP-1 cells
Monocytes/
macrophages 
from peripheral 
blood of healthy 
humans
Monocytes/
macrophages 
from synovial fluid 
of RA patients
Percentage of positive 
staining cells (%)
88.75 ± 2.32 97.17 ± 0.6* 99.23 ± 0.47 99.33 ± 0.38 99.18 ± 0.55 99.27 ± 0.39
Mean fluorescence 
intensity
192.72 ± 12.67 193.33 ± 15.83 202.1 ± 19.25 286.61 ± 
31.63#
78.32 ± 18.25 136.37 ± 28.16‡
Number 4 6 6 6 10 10
Values presented as the mean ± standard error (n = 4–10 independent samples per group). Expressions of CD147 on FLS from osteoarthritis or 
rheumatoid arthritis (RA) patients and monocytes/macrophages (including undifferentiated THP-1/phorbol 12-myristate 13-acetate [PMA]-
induced differentiated dTHP-1 cells, monocytes/macrophages from synovial fluid of rheumatoid arthritis patients or from peripheral blood of 
healthy humans) were measured by flow cytometry using fluorescein isothiocyanate-labeled anti-CD147 mAb. Analysis was conducted on a 
FACS™ brand flow cytometer. Two parameters of FLS and THP-1 cells were used: the percentage of positive staining cells, and the mean 
fluorescence intensity (denoting the quantity of CD147 expression on the surface of each cell).
*P < 0.05 versus OA FLS; #P < 0.05 versus undifferentiated THP-1 cells; ‡P < 0.05 versus monocytes from peripheral blood of healthy humans.Available online http://arthritis-research.com/content/8/2/R44
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Figure 1
RT-PCR analyses of CD147, MMP-2 and MMP-9 mRNA in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis (RA) patients, from osteoar- thritis (OA) patients, and in undifferentiated and differentiated THP-1 cells RT-PCR analyses of CD147, MMP-2 and MMP-9 mRNA in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis (RA) patients, from osteoar-
thritis (OA) patients, and in undifferentiated and differentiated THP-1 cells. Cells were collected and the total RNA isolated by electrophoresis and 
transferred to a nylon membrane. The membrane was hybridized with CD147-specific, MMP-2-specific and MMP-9-specific cDNAs, and then visual-
ized by autoradiography. (a) and (b) Expression of CD147, MMP-2 and MMP-9 mRNA in RA FLS (lanes 1, 3 and 2) was higher than that in OA FLS 
(lanes 4, 6 and 5). (a) and (c) Expression of CD147, MMP-2 and MMP-9 mRNA in RA FLS after co-culture with undifferentiated THP-1 cells (lanes 
7, 9 and 8) was higher than that in RA FLS (lanes 1, 3 and 2). (a) and (d) Expression of CD147 mRNA of differentiated THP-1 cells (dTHP-1, lane 
11) was higher than that of undifferentiated THP-1 cells (uTHP-1, lane 10). Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as the 
inner parameter. Values (ratio of density = experiment/GAPDH) are the means ± standard error (n = 4–6). *P < 0.05 (experimental groups versus 
control groups).Arthritis Research & Therapy    Vol 8 No 2    Zhu et al.
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(phenotype: <1% CD14, <1% CD68 and >98% CD90)
[13,14].
The human monocyte THP-1 cells (American Type Culture
Collection, Manassas, VA, USA) were cultured in RPMI 1640
medium supplemented with 10% FBS, 1% penicillin/strepto-
mycin and 2% L-glutamine at 37°C in a humidified atmosphere
of 5% CO2. For the induction of cell differentiation, cells (5 ×
105 to 106 per ml) were seeded in RPMI 1640 serum medium
with 200 nM phorbol 12-myristate 13-acetate (PMA) for 24
hours [15]. After incubation, the nonadherent cells were
removed by aspiration and the adherent cells were washed
with RPMI 1640 three times. THP-1 cells in RPMI 1640 with-
out PMA were used as control (undifferentiated) cells.
Monocytes from heparinized synovial fluid of RA patients were
isolated by the Ficoll–Hypaque (Sigma) gradient centrifuga-
tion method. The human monocytes were isolated from periph-
eral blood of healthy humans by Dynal magnetic human CD14
monocyte isolation kits (Dynal Biotech, Oslo, Norway) accord-
ing to the manufacturer's instructions.
To distinguish the effects of the differentiated and undifferen-
tiated cells, the THP-1 cells were co-cultured with FLS (1 ×
105 cells/35 mm dish) at a cell number ratio of 1.0:1.0 for 24
hours in serum-free DMEM. Undifferentiated THP-1 cells (non-
adherent cells) were washed thoroughly with PBS, and FLS
(adherent cells) were collected for RT-PCR detection.
Flow cytometry analysis
Expression of CD147 on the surface of the third to fifth pas-
sage of FLS derived from RA or OA synovium tissues were
detected by flow cytometry. Cells (5 × 105) were washed
three times with PBS and were then treated with fluorescein
isothiocyanate-conjugated anti-CD147 monoclonal antibody
IgG1 or fluorescein isothiocyanate-conjugated Mouse IgG1
used as the isotype control (BD Pharmingen, San Diego, CA,
USA) for 20 minutes in dark conditions. Cells were washed
with PBS and then analyzed by a FACS Calibur flow cytome-
try, and the data were processed using Cell Quest software
(BD Biosciences, San Jose, CA, USA). The positive cell count
and the mean fluorescence intensity (MFI) were determined by
flow cytometry.
Expression of CD147 on the surface of the differentiated or
undifferentiated THP-1 cells and the human monocytes/mac-
rophages from peripheral blood of healthy humans or from syn-
ovial fluid of RA patients was also detected by the same
method.
Reverse transcription-polymerase chain reaction
For analysis of MMP-2, MMP-9 and CD147 mRNA levels in
FLS derived from RA or OA synovium tissues and for analysis
of CD147 mRNA levels in differentiated and undifferentiated
THP-1 cells, total RNA was isolated from FLS (four samples
with OA FLS, six samples with RA FLS and six samples with
RA FLS co-cultured with undifferentiated THP-1 cells) and
from THP-1 cells using Trizol (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer's instructions. The isolation
was followed by the first-strand cDNA synthesis using True-
Script reverse transcriptase (BioRad, Hercules, CA, USA).
The cDNA was amplified by PCR using the specific primer set
for MMP-2, MMP-9 and CD147 or using glyceraldehyde phos-
phate dehydrogenase as an internal control.
The sequences of the upstream and downstream primers
were respectively as follows: 5'-ATGGGGCTGGAGCACTC-
CCAAG-3' and 5'-TGTGGCAGCACCAGGGCAGC-3' for
MMP-2 (1,070 bp); 5'-GGTCCCCCCACTGCTGGCCCT-
TCTACGGC-3' and 5'-CACCTCCACTCCTCCCTTTCC-3'
for MMP-9 (750 bp); 5'-ACATCAACGAGGGGGAGACG-3'
and 5'-GGCTTCAGACAGGCAGGACA-3' for CD147 (492
bp); and 5'-CTGAACGGGAAGCT CACTGG-3' and 5'-
TGAGGTCCACCACCCTGTTG-3' for glyceraldehyde phos-
phate dehydrogenase (313 bp). PCR analysis was performed
under the following conditions: denaturation at 94°C for 2 min-
utes and then 25–30 cycles of denaturation for 30 seconds at
94°C; renaturation for 60 seconds at 56°C for MMP-2, at
58°C for MMP-9 and at 57°C for CD147 and glyceraldehyde
phosphate dehydrogenase; and extension for 90 seconds at
72°C. The amplified products were analyzed by agarose gel
electrophoresis using 1% gel, followed by ethidium bromide
staining.
Gelatin zymography
Gelatin zymography was performed for detection of MMP
activity in conditioned medium. FLS and THP-1 cells were cul-
tured overnight using ordinary serum-containing DMEM. Then
FLS, THP-1 cells and the co-culture of FLS and THP-1 cells at
the ratio of 1.0:1.0 in serum-free medium were cultured for 24
hours in the presence or absence of HAb18G/CD147 antag-
onist peptide AP-9 (200 µg/ml), which was produced and
characterized in our laboratory based on HAb18G (amino acid
sequence YKLPGHHHHYRP) [16-18].
In our previous study, the binding site of AP-9 was confirmed
to be the HAB18G/CD147 molecule in the infected 293 cells.
AP-9 efficiently blocked the binding sites of HAb18G/CD147
on the cytomembrane and on the unit membrane in the cyto-
plasm of the 293 cells, and had an inhibitory effect on severe
acute respiratory syndrome coronavirus in vitro [16]. HAb18G
is a hepatoma-associated antigen cloned by hepatoma mono-
clonal antibody HAb18 from a human hepatocellular carci-
noma cDNA library. HAb18G is a highly glycosylated
transmembrane protein of 60 kDa with an ectodomain consist-
ing of two regions exhibiting the characteristics of the immu-
noglobulin superfamily. HAb18G has identical nucleotide acid
and amino acid sequences with those of CD147 [17].
HAb18G is a new member of the CD147 family and is abun-
dantly expressed in human hepatoma tissues and on the cellAvailable online http://arthritis-research.com/content/8/2/R44
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Figure 2
Gelatin zymography of culture medium conditioned by fibroblast-like synoviocytes (FLS) and THP-1 cells Gelatin zymography of culture medium conditioned by fibroblast-like synoviocytes (FLS) and THP-1 cells. Cells were cultured in serum-free media for 
24 hours, and the conditioned media were collected and analyzed for matrix metalloproteinase (MMP) activity by gelatin zymography. (a) Secretion 
and activation of MMPs in FLS from rheumatoid arthritis (RA) and osteoarthritis (OA) patients, THP-1 cells, RA FLS co-cultured with THP-1 cells and 
in co-cultured cells treated by AP-9 or SSP, and ethylenediamine tetraacetic acid or phenanthroline. Top two bands, MMP-9 gelatinase; lower two 
bands, MMP-2 gelatinase. (b) The value of proMMP-2 and MMP-2 activity of RA FLS was higher than that of OA FLS (six samples with RA FLS, four 
samples with OA FLS; P < 0.05). (c) The value of proMMP-9, MMP-9 and proMMP-2 activity of differentiated THP-1 cells (dTHP-1) was higher than 
that of undifferentiated THP-1 cells (uTHP-1) (n = 6, P < 0.05). (d) The value of proMMP-9, MMP-9 and proMMP-2 activity of RA FLS co-cultured 
with uTHP-1 was higher than that of co-cultured cells treated by AP-9 (n = 6, P < 0.05), while no inhibitory effects were found in irrelevant peptide 
SSP (n = 6, P > 0.05). (e) The value of proMMP-9, MMP-9, proMMP-2 and MMP-2 activity of RA FLS co-cultured with dTHP-1 was higher than that 
of co-cultured cells treated by AP-9 (n = 6, P < 0.05), while no inhibitory effects were found in irrelevant peptide SSP (n = 6, P > 0.05). Values are 
the means ± standard error (n = 4–6). *P < 0.05 (experimental groups versus control groups).Arthritis Research & Therapy    Vol 8 No 2    Zhu et al.
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surface of several hepatoma cell lines with a highly invasive
potential [5,18-21].
The irrelevant peptide SSP produced in our laboratory, a syn-
thetic epitope peptide of severe acute respiratory syndrome
coronavirus S-protein (amino acid sequence FFSTFKCY-
GVSA) was used as the control. Conditioned media were col-
lected and centrifuged to remove cellular debris and the
supernatant was collected and stored at -20°C. Each sample
suspension (20 µl) was mixed with SDS sample buffer without
reducing agent, followed by detection of the gelatinolytic activ-
ity and quantity in the conditioned media by gelatin zymogra-
phy [22,23]. In brief, the conditioned medium was resolved by
SDS-PAGE under non-reducing conditions using 8% separat-
ing gel containing 0.1% gelatin. The gels were then washed
twice in 2.5% (w/v) Triton X-100 for 30 minutes at room tem-
perature to remove SDS and were incubated in reaction buffer
containing 50 mmol/l Tris, 0.2 mol/l NaCl, 5 mmol/l anhydrous
CaCl2 and 2.5% Triton X-100 for 20 hours at 37°C. The buffer
was suitable for proteinase activity, enabling the renatured
proteinases to hydrolyze the copolymerized protein substrate
in a zone around their position of electrophoresis. The gels
were subsequently stained with 0.5% Coomassie blue (R-
250) and destained with buffer consisting of 20% methanol,
10% acetic acid and 70% distilled water for 30 minutes to vis-
ualize these zones of digestion as light areas against the darkly
stained protein background. The zymography gels were
scanned and analyzed using US National Institutes of Health
Image 1.6 software.
The same method was used to detect the secretion and acti-
vation of MMP-2 and MMP-9 of FLS co-cultured with human
monocytes/macrophages from peripheral blood of healthy
humans or from synovial fluid of RA patients.
Inhibition tests were conducted to verify that the bands of pro-
teolytic activity were MMPs. The MMP inhibitors, ethylenedi-
amine tetraacetic acid (EDTA) (5 mM; Sigma) and 1,10-
phenanthroline (20 mM; Sigma), were added separately to the
incubation buffer and gels were incubated for 20 hours as
described for zymography.
Invasion assay
The chemotactic cell invasion assay was performed using 24-
well transwell units (Costar, Cambridge, NY, USA), each with
an 8 µm pore size polycarbonate filter coated with matrigel (5
µg/ml in cold medium) to form a continuous thin layer. Prior to
the addition of the cell suspension of FLS, THP-1 cells and co-
culture cells (3 × 105) in serum-free medium in the presence
or absence of HAb18G/CD147 antagonist peptide AP-9, the
dried layer of matrigel matrix was rehydrated with medium
without FBS (450 µl). An irrelevant peptide SSP was used in
place of HAb18G/CD147 antagonist peptide AP-9 as the
control. Using 3T3-conditioned media as the chemoattractant,
the cells were then cultured for 24 hours at 37°C in a CO2
incubator. The cells remaining in the upper compartment were
completely removed with gently swabbing. The filter was fixed
and stained with colorimetric H & E. The cells that invaded
through the filter into the lower surface of the filter in five micro-
scopic fields of 150 × magnification were counted in each fil-
ter. Triplicate samples were conducted and the data were
expressed as the average cell number of 15 fields.
The same method was also used to detect the invasive ability
of FLS co-cultured with human monocytes/macrophages from
peripheral blood of healthy humans or from synovial fluid of RA
patients.
Statistical analysis
All values are expressed as the mean ± standard deviation.
Statistical analyses were performed with Student's t test using
SPSS software, and P < 0.05 was considered significant.
Results
Expression of CD147 on FLS from RA and OA patients
Expression of CD147 on FLS was evaluated by flow cytome-
try. Specifically, two parameters of flow cytometry were used:
the MFI, which is the quantity of CD147 expression on the sur-
face of each cell, and the percentage of positive staining cells.
The result showed that the percentage of positive staining
cells of CD147 on RA FLS was higher than that of OA FLS (P
< 0.05; Table 1). The MFI of CD147 on RA FLS and OA FLS
was no different (P > 0.05; Table 1).
Expression of CD147 on THP-1 and monocytes/
macrophages
The MFI of CD147 on PMA-induced differentiated human
monocyte line THP-1 cells was higher than that on the undif-
ferentiated THP-1 cells (P < 0.05; Table 1). The percentage of
positive staining cells of CD147 on differentiated and undiffer-
entiated THP-1 cells was no different (P > 0.05; Table 1). The
MFI of CD147 on the human monocytes/macrophages from
synovial fluid of RA patients was higher than that on the human
monocytes from peripheral blood of healthy humans (P  <
0.05; Table 1). The percentage of positive staining cells of
CD147 on human monocytes/macrophages from the synovial
fluid of RA patients and from peripheral blood of healthy
humans was no different (P > 0.05; Table 1).
Expression of CD147, MMP-2 and MMP-9 mRNA in FLS 
from RA and OA patients
The RT-PCR results were scanned and analyzed using US
National Institutes of Health Image 1.6 software. The results
indicated that the expressions of CD147, MMP-2 and MMP-9
mRNA were higher in RA FLS than those in OA FLS (Figure
1a,b). The expressions of CD147, MMP-2 and MMP-9 mRNA
in RA FLS increased after co-culture with THP-1 cells (Figure
1a,c). The expression of CD147 mRNA in THP-1 cells was
enhanced after THP-1 cells were treated with PMA for 24
hours (Figure 1a,d).Available online http://arthritis-research.com/content/8/2/R44
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Figure 3
Gelatin zymography of culture medium conditioned by fibroblast-like synoviocytes (FLS) and monocytes/macrophages Gelatin zymography of culture medium conditioned by fibroblast-like synoviocytes (FLS) and monocytes/macrophages. Cells were cultured in serum-
free media for 24 hours, and the conditioned media were collected and analyzed for matrix metalloproteinase (MMP) activity by gelatin zymography. 
(a) Secretion and activation of MMPs in rheumatoid arthritis (RA) FLS, monocytes/macrophages, RA FLS co-cultured with monocytes/macro-
phages, and in co-cultured cells treated by AP-9 or SSP, and ethylenediamine tetraacetic acid or phenanthroline. Top two bands, MMP-9 gelatinase; 
lower two bands, MMP-2 gelatinase. (b) The value of proMMP-2 and MMP-2 activity of monocytes from peripheral blood of healthy humans (Mo-PB) 
was lower than monocytes/macrophages from synovial fluid of RA patients (Mo-SF) (n = 10, P < 0.05). (c) The value of proMMP-9, MMP-9, 
proMMP-2 and MMP-2 activity of RA FLS co-cultured with Mo-PB was higher than that of co-cultured cells treated by AP-9 (n = 6, P < 0.05), while 
no inhibitory effects were found in irrelevant peptide SSP (n = 6, P > 0.05). (d) The value of proMMP-9, MMP-9, proMMP-2 and MMP-2 activity of 
RA FLS co-cultured with Mo-SF was higher than that of co-cultured cells treated by AP-9 (n = 6, P < 0.05), while no inhibitory effects were found in 
irrelevant peptide SSP (n = 6, P > 0.05). Values are the means ± standard error (n = 6–10). *P < 0.05 (experimental groups versus control groups).Arthritis Research & Therapy    Vol 8 No 2    Zhu et al.
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MMP release and activation in co-culture of RA FLS and 
THP-1 cells
Gelatin zymography showed that the secretion and activation
of MMP-2 and MMP-9 increased in the co-culture of RA FLS
and differentiated THP-1 cells compared with those in the co-
culture of RA FLS and undifferentiated THP-1 cells (P < 0.05;
Figure 2). The secretion and activation of proMMP-2 and
MMP-2 of RA FLS were higher than those of OA FLS (P <
0.05; Figure 2a,b). An increase was observed in the release of
MMP-9 in the differentiated THP-1 cells compared with that in
the undifferentiated THP-1 cells (P < 0.05; Figure 2a,c).
In inhibition tests, gelatin zymography showed that the protei-
nases were all inhibited by EDTA and phenanthroline (Figure
2a), which verified that these enzymes were all MMPs.
MMPs release and activation in co-culture of RA FLS and 
human monocytes/macrophages
The gelatin zymography results showed that MMP-9 and
MMP-2 secretion and activation increased in the co-culture of
RA FLS and human monocytes/macrophages from synovial
fluid of RA patients compared with those in the co-culture of
RA FLS and human monocytes from normal peripheral blood
(P < 0.05; Figure 3). The secretion and activation of proMMP-
9, MMP-9 and MMP-2 of human monocytes/macrophages
from synovial fluid of RA patients were higher than those of
human monocytes from normal peripheral blood (P < 0.05;
Figure 3a,b).
The inhibition tests showed the same results as those in gela-
tin zymography of RA FLS and THP-1 cells (Figure 3a).
Invasive potential of cells in co-culture of RA FLS and 
human monocytes/macrophages or THP-1 cells
A higher number of RA FLS (232 ± 26.29 cells/filter) were
found to have invaded through transwell chambers than that of
OA FLS (142.3 ± 11.02 cells/filter) (P < 0.05; Figure 4a,d). A
higher number of RA FLS co-cultured with differentiated THP-
1 cells (1055.67 ± 63.06 cells/filter) were found to have
invaded through transwell chambers than that of RA FLS co-
cultured with undifferentiated THP-1 cells (726 ± 83.86 cells/
filter) (P < 0.05; Figure 4b,d). RA FLS co-cultured with human
monocytes/macrophages from synovial fluid of RA patients
were found to have a higher number invade through the tran-
swell chambers (1655.67 ± 63.06 cells/filter) than that of RA
FLS co-cultured with human monocytes from normal periph-
eral blood (972.67 ± 59.21 cells/filter) (P < 0.05; Figure 4c).
Effect of HAb18G/CD147 antagonistic peptide AP-9 on 
MMP release and activation and on the invasion 
processes
HAb18G/CD147 antagonistic peptide AP-9 (200 µg/ml) was
found to have inhibitory effects on the MMP release and acti-
vation of co-cultured RA FLS and THP-1 cells (differentiated
and undifferentiated), and on co-cultured RA FLS and mono-
cytes/macrophages from healthy peripheral blood or rheu-
matic synovial fluid (P  < 0.05; Figures 2a,d,e and 3a,c,d).
However, the irrelevant peptide SSP was not found to have
inhibitory effects (P > 0.05; Figures 2a,d,e and 3a,c,d).
The invasion block assay showed that the amounts of cells
invaded through the matrigel-coated filter decreased after the
treatment with AP-9 (200 µg/ml) for 24 hours in RA FLS co-
cultured with THP-1 cells (undifferentiated and differentiated).
The inhibitory rate of invasive potential in RA FLS co-cultured
with undifferentiated THP-1 cells and RA FLS co-cultured with
differentiated THP-1 cells was 39.53% and 22.8%, respec-
tively (P < 0.05; Figure 4b,d), while no inhibitory effects were
found in the irrelevant peptide SSP (P > 0.05; Figure 4b,d).
The inhibitory rate of invasive potential in RA FLS co-cultured
with human monocytes/macrophages from the synovial fluid of
RA patients and RA FLS co-cultured with human monocytes
from normal peripheral blood was 44.74% and 37.73%,
respectively (P < 0.05; Figure 4c), while no inhibitory effects
were found in the irrelevant peptide SSP (P > 0.05; Figure
4c).
Discussion
FLS and MLS at the cartilage-pannus junction of RA patients
contribute most to the joint destruction and they produce a
great amount of MMPs. These enzymes act in a synergistic
manner to destroy connective tissue components [24,25]. The
combination of MMPs is capable of degrading all essential
extracellular matrix components of the synovial membrane,
articular cartilage and subchondral bone. Imbalanced activity
between MMPs and tissue inhibitors of metalloproteinases
caused by enhanced expression of CD147 eventually leads to
joint destruction in RA [26-28].
CD147 is more highly expressed on human carcinoma cells
than on normal cells and its expression correlates with the
MMP expression level and the cancer invasive potential [29-
32]. The aggressive characteristics of RA synovium are similar
to those of neoplastic tissues [33]. The proliferating mass of
synoviocytes locally invades the cartilage and bone, destroy-
ing the joint. MMPs, mainly produced in FLS, play a central role
in arthritic joint destruction. Beyond the proof that the expres-
sions of MMP-2 and MMP-9 as well as the invasive potential
of RA FLS are higher than those of OA FLS, we have also
found in this study, by cell isolation and culture, that the
expression of CD147 on RA FLS is higher than that on OA
FLS.
The monocyte/macrophage lineage, especially MLS, is also
known to play an important role in RA pathogenesis. In this
study, we found that expressions of CD147, MMP-2 and
MMP-9 of differentiated THP-1 cells or monocytes/macro-
phages from synovial fluid of RA patients are higher than those
of undifferentiated THP-1 cells or monocytes from peripheral
blood of healthy humans. PMA might be a main upregulativeAvailable online http://arthritis-research.com/content/8/2/R44
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Figure 4
Invasive potential in co-culture of rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and monocytes/macrophages or THP-1 cells, and RA/ osteoarthritis (OA) FLS alone Invasive potential in co-culture of rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and monocytes/macrophages or THP-1 cells, and RA/
osteoarthritis (OA) FLS alone. The invasive potential was evaluated in transwell chambers as described in Patients and methods. Briefly, cells were 
suspended in serum-free media supplemented with or without AP-9 or SSP (200 µg/ml) and seeded into the upper side of the matrigel (5 µg/ml)-
coated chambers. After incubation for 24 hours at 37°C, the number of invaded cells was determined using a colorimetric H & E assay. Black arrow, 
FLS; white arrow, THP-1 cells (f × 200). (a) and (d) The invasive potential of RA FLS was higher than that of OA FLS (P < 0.05; six samples with RA 
FLS, four samples with OA FLS). (b) and (d) the invasive potential of RA FLS co-cultured with undifferentiated THP-1 cells (uTHP-1) and differenti-
ated THP-1 cells (dTHP-1) and the invasive potential of co-cultured cells inhibited by AP-9 (P < 0.05, RA FLS+ uTHP-1 vs RA FLS+ uTHP-1+ AP-
9 and RA FLS+ dTHP-1 vs RA FLS+ dTHP-1+ AP-9; n = 6, respectively), while no inhibitory effects were found in irrelevant peptide SSP (P > 0.05, 
RA FLS+ uTHP-1 vs RA FLS+ uTHP-1+ SSP and RA FLS+ dTHP-1 vs RA FLS+ dTHP-1+ SSP; n = 6, respectively). (c) The invasive potential of 
RA FLS co-cultured with monocytes/macrophages from synovial fluid of RA patients (Mo-SF) and monocytes from peripheral blood of healthy 
humans (Mo-PB) and the invasive potential of co-cultured cells inhibited by AP-9 (n = 10, P < 0.05), while no inhibitory effects were found in irrele-
vant peptide SSP (n = 10, P > 0.05). Values are the means ± standard error (n = 4–10). *indicates P < 0.05 (experimental groups versus control 
groups). Stars indicate P < 0.05 (RA FLS co-cultured with dTHP-1 versus RA FLS co-cultured with uTHP-1, and RA FLS co-cultured with Mo-SF 
versus RA FLS co-cultured with Mo-PB).Arthritis Research & Therapy    Vol 8 No 2    Zhu et al.
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factor that enhances expression of CD147 on the differenti-
ated THP-1 cells. Some cytokines in the synovial fluid of RA
patients, such as interferon gamma and granulocyte–macro-
phage colony-stimulating factor, may also enhance the expres-
sion of CD147 on the monocytes/macrophages from synovial
fluid of RA patients. The overexpression of CD147 on differen-
tiated monocytes/macrophages suggests that CD147 may be
important in the early phases of direct cell migration and of
both autocrine and paracrine stimulation of MMP expression.
However, further work is needed to test this supposition.
In our previous study, we found that CD147 was expressed
predominantly on the MLS and FLS in the lining and sublining
layers of RA synovium, and macrophages acted as the ampli-
fier of the pathogenetic cascade in RA via the increase of
MMP production by interacting macrophages with fibroblasts
[10]. To explore the effect of cell–cell interaction on the pro-
duction of MMPs and the invasiveness of RA synoviocytes, RA
FLS were co-cultured with THP-1 cells in the present study.
We have found that the expression of CD147 on RA FLS is
enhanced by cell–cell interaction, and that the secretion and
activation of MMPs and the invasive potential of RA FLS are
also enhanced. These results suggest that the overexpression
of CD147 on macrophages may accelerate the production of
MMPs and the invasive ability of RA FLS by cell–cell interac-
tion. The overexpression of CD147 on FLS and the monocyte/
macrophage lineage, especially on MLS, suggests that
CD147 may be important in both autocrine and paracrine stim-
ulation of MMPs. From the findings that homophilic CD147
binding has occurred in the context of both heterotypic and
homotypic cell–cell interactions and that CD147 can be a
receptor in itself to induce MMP production, not only in primary
fibroblast cells but also in tumor cells themselves [34], we pre-
sume that the increased expression of CD147 on FLS and the
monocyte/macrophage lineage, especially on MLS, in RA syn-
ovium could possibly induce MMP production through interac-
tion.
To further confirm the effect of cell–cell interactions in rheu-
matic joints, monocytes/macrophages from synovial fluid of
RA patients and from peripheral blood of healthy humans were
co-cultured with RA FLS in this study. The environments of co-
cultured RA FLS and monocytes/macrophages from synovial
fluid of RA patients or from peripheral blood of healthy humans
are more like the real environment in vivo than that of co-cul-
tured RA FLS and THP-1 cells. The results from this co-culture
were consistent with those of RA FLS co-cultured with THP-1
cells, indicating that the overexpression of CD147 induces
elevated levels of MMPs and their activated forms in RA FLS
– and the elevated levels of MMPs in turn enhance the invasive
ability of RA FLS.
In this study, CD147 antagonistic peptide was added in the
condition medium of co-cultured cells. We have found that the
addition of CD147 antagonistic peptide has some inhibitory
effect not only on the MMP production, but also on the invasive
potential of the co-cultured FLS. The inhibition of MMP-2 and
MMP-9 production by CD147 antagonistic peptide indicates
that CD147 may induce MMP-2 and MMP-9 production. The
mechanism by which CD147 regulates MMP-2 and MMP-9
production is largely unclear, although a recent study has sug-
gested that the mitogen-activated protein kinase p38 pathway
may be involved during MMP induction in dermal fibroblasts
[35]. Our previous studies have indicated that overexpression
of HAb18G/CD147 enhances metastatic potentials in human
hepatoma cells by disrupting the regulation of store-operated
Ca2+ entry by nitric oxide/cGMP. CD147 is required to medi-
ate the effect of HAb18G/CD147 on the secretion and activa-
tion of MMPs and metastasis-related processes in human
hepatoma cells by disrupting the regulation of nitric oxide/
cGMP-sensitive intracellular Ca2+ mobilization [19,20]. These
findings also indicate that CD147 is involved in promoting the
secretion and activation of MMPs, which in turn increases the
invasive potential of FLS. These results also suggest that
CD147 expression may be correlated to MMP (MMP-2, MMP-
9) secretion, activation and invasive potential in RA FLS.
Very low levels of CD147 have been reported in most normal
adult tissues, including the epidermis, retinal pigment epithe-
lium, and breast lobules and ductules. CD147 may therefore
play a physiologic role in tissue remodeling by inducing MMPs
[36-39]. A correlation between CD147 and progressive joint
destruction in RA is suggested in this study based on the find-
ings that the overexpression of CD147 on monocytes can
facilitate enhancement of the production of MMPs and the
invasion ability of FLS, and that CD147 antagonistic peptide
can block the enhancement.
Conclusion
We conclude in this study that the increased expression of
CD147 on FLS and macrophage-like cells in RA may be
responsible for the elevated MMP secretion and the activation
and the invasive potential of the cell, all of which may contrib-
ute to the cartilage and bone destruction characteristic of RA.
These findings, together with a better understanding of the
relationship between CD147 and RA, and of the possible
mechanism and regulation of the effect of CD147 on MMP
production, will help in the development of innovative thera-
peutic interventions for RA.
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